Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-02-07 4:43 pm | N/A 2034-01-24 | GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 4:37 pm | N/A 2033-01-26 | GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:00 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-25 4:17 pm | N/A 2032-01-24 | GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 4:35 pm | N/A 2031-03-25 | GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 4:32 pm | N/A 2030-03-12 | GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-01-20 Option Award | 2020-01-22 5:02 pm | N/A 2030-01-20 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-01-03 5:15 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 0 | $0 | 40 (Direct) | View |